Stay informed and share your thoughts with our LinkedIn community.
Get in touch with our media relations team
Global Media Relations
Our latest news
Legacy Novozymes is delivering solid growth and earnings in a year characterized by changing market demands, with 6% organic sales growth in Q4 and 5% in 2023. This marks the last financial reporting from legacy Novozymes, and the new company, Novonesis, is already a reality.
Today, the proposed combination of the legacy companies Novozymes and Chr. Hansen is successfully completed, establishing the company Novonesis. Novonesis is a world-leading biosolutions partner for better business, healthier lives, and a healthier planet. The combined company brings together 10,000 people worldwide and an expertise that spans more than 30 different industries. Novonesis is already assisting companies around the world in meeting both business needs and the needs of the planet.
Novozymes and Chr. Hansen have announced that the name of the future combined company will be ‘Novonesis’. Novonesis means ‘A new beginning’ and derives from the Greek word ‘genesis’. The name reflects a new era of biosolutions where innovation in biological sciences and technology will offer solutions to solve some of the biggest challenges facing humanity.
Our image center
Ways to stay in touch
Join our mailing list to get our press releases, financial, and industry news delivered straight to your inbox.
The biosolutions bulletin
Everything you need to know about biosolutions, delivered monthly to your inbox.
Stay updated through Instagram.
Stay updated through Facebook.
Stay updated through X.